In a bid to revolutionize the pain management and addiction treatment landscape, Rusan Pharma has unveiled its state-of-the-art active pharmaceutical ingredient (API) facility in Pithampur, Madhya ...
—The Noramco Group Addresses Critical Supply Chain Challenges, Offering Comprehensive Active Pharmaceutical Ingredients (API) and Drug Product Solutions— WILMINGTON, Del.--(BUSINESS WIRE)--Noramco, a ...
POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients (API) - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Active ...
What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...
After Zhejiang Huahai Pharmaceutical’s tainted valsartan API and Changchun Changsheng Life Sciences’ fabricated vaccine production data exposé, China’s drug industry could be dealing with another ...
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence ...
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...
EMPOWER'S KAI Medical Laboratory Also Supporting API Pharma With Health Canada Submission of COVID Rapid Antigen Test and Signs National Distribution Agreement VANCOUVER, BC / ACCESSWIRE / November 30 ...
On 4 July 2025, the EC fined Alchem and its subsidiary EUR 489,000 for their role in a long-running cartel concerning the active pharmaceutical ingredient SNBB, used in the production of Buscopan and ...
DUBLIN--(BUSINESS WIRE)--The "Pharma 4.0" report has been added to ResearchAndMarkets.com's offering. This report provides detailed exposure to the Pharma 4.0 market. This report also highlights the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results